Physician profile
Phan Nguyen
NPI 1649378761
$14,368.14
in general payments reported to CMS, 2019-2025
41 companies · $999 in 2025
The $999 reported for 2025 was more than what 92% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $84.22 · 2021: $464 · 2022: $1,135 · 2023: $632 · 2024: $10K · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,712 · Food and Beverage: $2,279 · Travel and Lodging: $1,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,712.27 |
| Food and Beverage | $2,279.34 |
| Travel and Lodging | $1,129.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,995.35 | 2022-2024 | |
| Astellas Pharma US INC | $422.35 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $415.13 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $339.82 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $244.77 | 2022-2025 | Slynd |
| Abbvie INC. | $240.24 | 2019-2025 | |
| Cardiovascular Systems INC. | $239.13 | 2021 | |
| Cook Medical LLC | $224.56 | 2021 | |
| Pfizer INC. | $220.61 | 2019-2025 | |
| Medtronic, INC. | $183.17 | 2022 | |
| Exact Sciences Corporation | $178.14 | 2023-2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $147.08 | 2019-2022 | |
| Organon LLC | $127.33 | 2022-2025 | Nexplanon, Jada System |
| Janssen Pharmaceuticals, INC | $117.73 | 2022 | |
| Merck Sharp & Dohme LLC | $114.12 | 2019-2025 | Gardasil 9, Gardasil |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $112.69 | 2022 | |
| Medtronic Vascular, INC. | $108.03 | 2019 | |
| Millicent US INC | $96.80 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Myovant Sciences INC. | $81.71 | 2022 | |
| Lupin INC. | $80.34 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $72.52 | 2019-2020 | |
| Coopersurgical, INC. | $71.25 | 2019-2024 | Summit Doppler, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $58.45 | 2025 | |
| Hologic Sales and Service, LLC | $46.26 | 2019-2025 | Omni Hysteroscope |
| Lilly USA, LLC | $44.52 | 2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $39.70 | 2024-2025 | Wegovy |
| Ethicon US, LLC | $35.90 | 2019-2022 | |
| Duchesnay USA Incorporated | $35.75 | 2019 | |
| Evofem Biosciences, INC. | $32.98 | 2022 | |
| Avion Pharmaceuticals | $31.33 | 2022 | |
| Glaxosmithkline, LLC. | $28.67 | 2019-2022 | |
| Covidien LP | $26.89 | 2019 | |
| Allergan, INC. | $25.88 | 2019 | |
| Agile Therapeutics, INC. | $24.61 | 2022 | |
| Shield Therapeutics INC | $21.61 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.44 | 2022 | |
| Davol INC. | $19.08 | 2024 | Arista Ah Flexitip |
| Aspira Women'S Health INC | $15.94 | 2019 | |
| Olympus America INC. | $15.08 | 2019 | |
| Meditrina | $13.18 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phan Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.